Contact DCEG
Sitemap
Search
Staff Directory
Awards
Events
Distinguished Lecture Series
Spotlight on Staff
Fellowships in Molecular Epidemiology
Opportunities in Prostate Cancer Research
Hormonal and Reproductive Epidemiology Fellows
Breast Cancer
Prostate Cancer
Other Hormone Related Malignancies
Cervical Cancer and Other HPV-Related Studies
Testicular Cancer
Hepatobiliary Cancers
Ovarian and Endometrial Cancers
Cohorts with Unique Exposures
Methodologic Studies
Cohorts with Unique Exposures
Useful Links
Back to DCEG Main Site
Biostatistics
Clinical Genetics
Core Genotyping Facility
Genetic Epidemiology
Hormonal and Reproductive Epidemiology
Infections and Immunoepidemiology Branch
Laboratory of Translational Genomics
Nutritional Epidemiology
Occupational and Environmental Epidemiology
Radiation Epidemiology
Employment Opportunities
View a list of current job opportunities with DCEG >
Hormonal and Reproductive Epidemiology
Publications
Publications
All HREB Publications
Press Releases and Important Published Papers
Breast Cancer
Cervical Cancer
Ovary and Endometrial Cancer
Prostate and Testicular Cancer
Breast Cancer
Brinton LA, Lubin JH, Murray MC, Colton T, Hoover RN.
Mortality rates among augmentation mammoplasty patients: An update
. (pdf)
Epidemiology
2006 March;17(2):162-9.
García-Closas M, Egan KM, Newcomb PA et al.
Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses
. (pdf)
Hum Genet
2006 May;119(4):376-88.
García-Closas M, Brinton LA, Lissowska J et al.
Established breast cancer risk factors by clinically important tumour characteristics
.
Br J Cancer
2006 Jul 3;95(1):123-9.
Lissowska J, Brinton LA, Zatonski W et al.
Tobacco smoking, NAT2 acetylation genotype and breast cancer risk
.
Int J Cancer
2006 May 17.
Falk RT, Fears TR, Xu X et al.
Urinary estrogen metabolites and their ratio among Asian American women
. (pdf)
Cancer Epidemiol Biomarkers Prev
2005 January;14(1):221-6.
Back to List
Cervical Cancer
Cervical Cancer: Screening and Testing
Cervical Cancer Home Page
Task Force Announces New Cervical Cancer Screening Guidelines
01/22/2003.
Human Papillomaviruses and Cancer
Hildesheim A, Berrington de González A.
Etiology and prevention of cervical adenocarcinomas
. (pdf)
J Natl Cancer Inst
2006 March 1;98(5):292-3.
Jeronimo J, Schiffman M.
Colposcopy at a crossroads
. (pdf)
Am J Obstet Gynecol 2006
May 2;Available at: URL: PM:16677597.
Schiffman M, Castle PE.
When to test women for human papillomavirus
. (pdf)
BMJ
2006 January 14;332(7533):61-2.
Sherman ME, Carreon JD, Schiffman M.
Performance of cytology and human papillomavirus testing in relation to the menstrual cycle
. (pdf)
Br J Cancer
2006 Jun 5;94(11):1690-6.
Castle PE, Solomon D, Schiffman M, Wheeler CM.
Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities
. (pdf)
J Natl Cancer Inst
2005 July 20;97(14):1066-71.
Schiffman M, Herrero R, Desalle R et al.
The carcinogenicity of human papillomavirus types reflects viral evolution
. (pdf)
Virology
2005 June 20;337(1):76-84.
Schiffman M, Castle PE.
The promise of global cervical-cancer prevention
. (pdf)
N Engl J Med
2005 November 17;353(20):2101-4.
Wang SS, Walker JL, Schiffman M, Solomon D.
Evaluating the risk of cervical precancer with a combination of cytologic, virologic, and visual methods
. (pdf)
Cancer Epidemiol Biomarkers Prev
2005 November;14(11):2665-8.
Back to List
Ovary and Endometrial Cancer
Brinton LA, Lacey JV Jr, Trimble EL.
Hormones and endometrial cancer-new data from the Million Women Study
. (pdf) (Comment on "Endometrial cancer and hormone replacement therapy in the Million Women Study").
Lancet
2005;365:1517-8.
Brinton LA, Sakoda LC, Sherman ME et al.
Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors
. (pdf)
Cancer Epidemiol Biomarkers Prev
2005 December;14(12):2929-35.
Brinton LA, Westhoff CL, Scoccia B et al.
Causes of infertility as predictors of subsequent cancer risk
.
Epidemiology
2005 July;16(4):500-7. (pdf, 301kb)
Lacey JV Jr, Brinton LA, Lubin JH, Sherman ME, Schatzkin A, Schairer C.
Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women
. (pdf)
Cancer Epidemiol Biomarkers Prev
2005 July;14(7):1724-31.
Sherman ME, Carreon JD, Lacey JV Jr, Devesa SS.
Impact of hysterectomy on endometrial carcinoma rates in the United States
. (pdf)
J Natl Cancer Inst
2005;97(2):1700-2.
Brinton LA, Lubin JH, Murray MC, Colton T, Hoover RN.
Mortality rates among augmentation mammoplasty patients: An update
. (pdf)
Epidemiology
2006 March;17(2):162-9.
Back to List
Prostate and Testicular Cancer
McGlynn KA, Graubard BI, Nam JM, Stanczyk FZ, Longnecker MP, Klebanoff MA.
Maternal hormone levels and risk of cryptorchism among populations at high and low risk of testicular germ cell tumors
. (pdf)
Cancer Epidemiol Biomarkers Prev
2005 July;14(7):1732-7.
Hsing AW, Chokkalingam AP.
Prostate cancer epidemiology
. (pdf)
Front Biosci
2006 May 1;11:1388-413.
Hsing AW, Chua S Jr, Gao Y-T, Deng J, Stanczyk FZ.
Insulin resistance and prostate cancer risk
. (pdf)
J Natl Cancer Inst
2003;95(1):67-71.